compound e (Tocris)
Tocris is a verified supplier 
Tocris manufactures this product 
94
Structured Review
Tocris
compound e
Compound E, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 37 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compound/Compound+E/pm42894639-125-155-157
Average 94 stars, based on 37 article reviews
Compound E, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 37 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compound/Compound+E/pm42894639-125-155-157
Average 94 stars, based on 37 article reviews
compound e - by Bioz Stars,
2026-11
94/100 stars
Images
Related Articles
other:Article Title: Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington's Disease. Article Snippet: Huntington’s disease (HD) is caused by an expanded CAG trinucleotide repeat in exon 1 of the huntingtin (HTT) gene.. We report the design of a series of HTT pre-mRNA splicing modulators that lower huntingtin (HTT) protein, including the toxic mutant huntingtin (mHTT), by promoting insertion of a pseudoexon containing a premature termination codon at the exon 49−50 junction.. The resulting transcript undergoes nonsense-mediated decay, leading to a reduction of HTT mRNA transcripts and protein levels. Article Title: Mas-related G protein-coupled receptor C11 (Mrgprc11) induces visceral hypersensitivity in the mouse colon: A novel target in gut nociception? Article Snippet: Abbreviations: BAM(8‐22), Bovine adrenal medulla peptide (8‐22); cDNA, complementary DNA; CGRP, Calcitonin gene‐related peptide; CRD, Colorectal distension; Cy3, Cyanine 3; DapB, 4‐hydroxy‐tetrahydrodipicolinate reductase; DRG, Dorsal root ganglion; EMG, Electromyography; FB, Fast blue; FITC, Fluorescein‐isothiocyanate; GPCR, G protein‐coupled receptor; hprt1, Hypoxanthine phosphoribosyltransferase 1; IBD, Inflammatory bowel disease; IBS, Irritable bowel syndrome; il‐1β, Interleukin‐1β; il‐6, Interleukin‐6; MPO, Myeloperoxidase; Mrgpr, Mas‐related G protein‐coupled receptor; NeuN, Neuronal nuclei; PBS, Phosphate‐buffered saline; PFH, Paraformaldehyde; PPIB, Peptidyl‐prolyl cis‐trans isomerase B; qPCR, quantitative PCR; rps29, ribosomal protein s29; tnf‐α, Tumor necrosis factor α; VMR, Visceromotor response.. 1Laboratory of Cell Biology and Histology, University of Antwerp, Antwerp, Belgium 2Laboratory of Experimental Medicine and Pediatrics, Division of Gastroenterology, University of Antwerp, Antwerp, Belgium 3Laboratory of Human Anatomy and Embryology, Division ASTARC, University of Antwerp, Antwerp, Belgium Article Title: Methods for treating cancer Article Snippet: The compound of Formula (I) (also known as iP300w) can be prepared as described in International Patent Application Publication Number WO2016/044770. Concentration Assay:Article Title: Dendritic synapse geometry optimizes binaural computation in a sound localization circuit Article Snippet: .. For glutamate uncaging, the caged ATPase Assay:Article Title: Decanoic acid inhibits mTORC1 activity independent of glucose and insulin signaling Article Snippet: Immunoprecipitation GFP-TrapA beads were used for Immunoprecipitation of GFP-fusion proteins (Chromotek, gta). .. ATPase assay Dictyostelium cells (wild type or UBXD18- expressing Ddp97-RFP) in the exponential phase of growth were treated for 24 hours with Expressing:Article Title: Decanoic acid inhibits mTORC1 activity independent of glucose and insulin signaling Article Snippet: Immunoprecipitation GFP-TrapA beads were used for Immunoprecipitation of GFP-fusion proteins (Chromotek, gta). .. ATPase assay Dictyostelium cells (wild type or UBXD18- expressing Ddp97-RFP) in the exponential phase of growth were treated for 24 hours with |
![Reaction schemes and LC-MS analysis of Pp UGTs reactions with diosgenin and pennogenin . ( a ) Biosynthesis of <t>trillin</t> mediated by UGT91BP2 and UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of diosgenin. ( b ) Extracted ion chromatograms (EICs) of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and diosgenin showing the formation of trillin, as compared to the authentic trillin standard. Control is the empty expression vector. ( c ) MS spectra of the enzymatic reaction products in hydrogen and sodium ion adducts compared to the fragmentation pattern of the trillin standard. The product molecular ions [M + H] + and [M +Na] + and the feature fragment ion [M + H − Glc] + with m / z 415.32 are marked. Of note, additional peaks observed in the diosgenin EIC ( m / z 415.32) for UGT703R1–3 might correspond to substrate isomeric impurities, in-source adducts, or minor non-enzymatic by-products; these peaks, which arose from the extracted ion flow of the substrate m / z , did not co-elute with the product, trillin , and therefore did not affect the interpretation of the product formation. ( d ) Biosynthesis of pennogenin 3- O -glucoside mediated by the UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of pennogenin. ( e ) EICs of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and pennogenin showing the formation of pennogenin 3- O -glucoside, compared to the control empty expression vector. ( f ) MS/MS spectra ([M + H – Glc] + and [M + H – Glc − H 2 O] + ) of the enzymatic reaction products.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_3502/pmc13123502/pmc13123502__gr2.jpg)
